SC144@HABN treatment also induced proliferation (Ki67+) and activation (granzyme B+) of tumor-infiltrating CD8+ T-cells, as compared with SC144 treatment (p < 0.01, Fig. 3e, f). The gene discussed is CD8A; the disease is neoplasm.